Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, adalimumab, Appeal, attached, automatically, azathioprine, cyclosporine, Demurrer, Denman, DGCL, Director, Domestication, exacerbation, Exhibit, eye, gevokizumab, Guerrero, Harwell, hereto, herewith, hired, HUMIRA, immunosuppressive, intention, intermediate, John, Krawiec, LUVENIQ, Lux, mycophenalate, Myfortic, NIU, ophthalmology, organizational, Paul, permanent, posterior, preliminary, provisional, rapamycin, refractory, release, resignation, resigned, Rubin, Santen, secondary, Senate, SJIA, sodium, suitable, Van, Varian, voclosporin, Young
Removed:
acne, Aphton, behalf, Certification, Chapter, chose, Comparatively, compound, decided, delisted, depending, discontinued, duly, eradication, gastrointestinal, gel, impetigo, inconclusive, irritation, peptide, pertaining, reformulate, reformulated, registrant, skin, superficial, thereunto, title, topical, unamortized, undersigned, vehicle
Filing tables
Filing exhibits
XOMA similar filings
Filing view
External links